For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220429:nRSc8952Ja&default-theme=true
RNS Number : 8952J Eco Animal Health Group PLC 29 April 2022
29 April 2022
ECO Animal Health Group PLC
BLOCK LISTING RETURN
Date: 29 April 2022
Name of applicant: ECO Animal Health Group plc
Name of scheme: Executive Share Option Scheme and Unapproved Share Option Scheme
Number and class of securities originally listed and the date of admission: 1,500,000 ordinary shares of 5 pence each on 20 July 2017
Period of return: From: 1 May 2021 To: 29 April 2022
Balance of unallotted securities under scheme(s) from previous return: 393,005
Plus: The amount by which the block scheme(s) has been increased since the 0
date of the last return (if any increase has been applied for):
Less: Number of securities issued/allotted under scheme(s) during period: 17,500
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 375,505
For further information, please contact:
020 8447 8899
ECO Animal Health Group plc
David Hallas (CEO)
Christopher Wilks (CFO)
IFC Advisory 020 3934 6630
Graham Herring
Zach Cohen
Singer Capital Markets (Nominated Adviser & Joint Broker) 020 7496 3000
Mark Taylor
George Tzimas
Investec (Joint Broker) 020 7597 5970
Gary Clarence
Alex Penney
Carlo Spingardi
Peel Hunt LLP (Joint Broker) 020 7418 8900
Dr Christopher Golden
James Steel
Equity Developments 020 7065 2692
Hannah Crowe
Matt Evans
About ECO Animal Health
ECO Animal Health Group plc researches, develops and commercialises products
for livestock. Our business strategy is to generate shareholder value by
achieving the maximum sales potential from the existing product portfolio
whilst investing in Research and Development ("R&D") for new products,
particularly vaccines, and seeking to in-license new products.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BLREAELNALAAEFA